Atalay, Selma, Juul M.P.A. van den Reek, Marisol E. Otero, Marcellus D. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein I. Koetsier, et al. “Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared With Standard Psoriasis Care: A Cost-Utility Analysis of the CONDOR Study”. Acta Dermato-Venereologica 100, no. 19 (December 1, 2020): 1–7. Accessed May 10, 2026. https://medicaljournalssweden.se/actadv/article/view/1863.